SSP027 Lenzetto® 1.53mg/dose transdermal spray (SUBSTITUTION)

The Department of Health and Social Care (DHSC) had issued a substitution Serious Shortage Protocol (SSP) for Lenzetto® 1.53mg/dose transdermal spray in response to a significant ongoing supply disruption. It has now expired as there is now sufficient stock to meet normal demands.

SSP027 for Lenzetto® 1.53mg/dose transdermal spray expired on Friday 13th January 2023.

Resources for SSPs are available from NHS BSA SSP web page